Ventricular Arterial Coupling: A Novel Echocardiographic Risk Factor for Disease Progression in Pediatric Dilated

Christine A Capone1, Jacqueline M Lamour2, Josemiguel Lorenzo2

  • 1Division of Pediatric Cardiology, Department of Pediatrics, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Avenue, R1, 10467, Bronx, NY, USA. christine.capone@gmail.com.

Pediatric Cardiology
|November 12, 2018
PubMed

Insights

A higher ventricular arterial (VA) coupling ratio is linked to worse outcomes in children with dilated cardiomyopathy (DCM). This non-invasive measure may help predict heart failure progression and guide treatment in pediatric DCM patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiovascular Physiology

Background:

  • Ventricular arterial (VA) coupling is a known predictor of outcomes in adult heart failure (HF).
  • Limited data exist on the association of VA coupling with prognosis in pediatric dilated cardiomyopathy (DCM).

Purpose of the Study:

  • To investigate the relationship between the VA coupling ratio and adverse outcomes in pediatric DCM patients.
  • To determine if VA coupling can predict the need for mechanical circulatory support, transplant, or death in children with DCM.

Main Methods:

  • A case-control study involving 48 pediatric DCM patients and 97 age-gender matched controls.
  • Non-invasive measurement of VA coupling ratio, arterial elastance, and left ventricular (LV) elastance.
  • Multivariate analysis, including CART analysis, to identify predictors of outcome.

Main Results:

  • DCM patients exhibited higher arterial elastance, lower LV elastance, and a significantly higher VA coupling ratio compared to controls.
  • Patients experiencing adverse outcomes (mechanical support, transplant, or death) had higher NYHA class, lower LV elastance, higher arterial elastance, and a markedly elevated VA coupling ratio.
  • VA coupling ratio was identified as the sole and primary discriminator of poor outcome in multivariate CART analysis.

Conclusions:

  • An elevated VA coupling ratio is significantly associated with worse outcomes in pediatric DCM.
  • VA coupling shows promise as a bedside tool for assessing pediatric DCM severity and guiding therapeutic strategies.
  • Further research into VA coupling may elucidate mechanisms of pediatric HF and identify novel treatment targets.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
568
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
490
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
538
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378